AQUA PHARMA GROUP AS

Operating

Aqua Pharma

Salg og utvikling av produkter for parasittbehandling innen akvakultur samt investering og eierskap i selskaper med tilsvarende virksomhet.

Eierskap og selskapsutvikling i datterselskaper og konsulentvirksomhet.

Organization

CEO: ER
Elvin Ronald Bugge1959
Chairman of the board: MG
Marco Giannuzzi1974
Years since formation: 7 years; since Apr 23, 2019
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 21,139,900; 1 share class
Total number of shareholders: 2; 1 company, 1 person
Belongs to group of

Financials

Total operating income 2025: 169,261,838; NOK
Annual total result 2025: 80,061,632; NOK
Total equity 2025: 314,452,459; NOK

Last update: Aug 31, 2026

Management

Management / administration

Name	Role	Shares
ER Elvin Ronald Bugge 1959	Managing Director/CEO	17.52 % indirectly

Board

Name	Role	Shares
MG Marco Giannuzzi 1974	Chairman	-
EB Eirik Bugge 1995	Board Member	15 % indirectly
IH Ines Hurtado Dominguez 1972	Board Member	-
HC Heidi Camilla Sagen-Ohren 1972	Board Member	-

Others

Name	Role	Shares
T TELL NORGE AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
ER Elvin Ronald Bugge 1959	Managing Director/CEO	17.52 % indirectly
EB Eirik Bugge 1995	Board Member	15 % indirectly
PT Petter Tofte 1993	-	3.33 % indirectly
ET Erling Tofte 1995	-	3.33 % indirectly
MT Mathea Tofte 1997	-	3.33 % indirectly

Last update: Feb 14, 2026

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
A AQUATIQ GROUP AS	Ordinary shares	10,569,950	50 %
CA Chemicals And Plastics Holdi Solvay	Ordinary shares	10,569,950	50 %

Shares owned by the AQUA PHARMA GROUP AS

Name	Share class	Total number of shares	Share
A AQUA PHARMA AS	Ordinary shares	100	100 %

Last update: Jun 2, 2025

Group structure

AQUA PHARMA GROUP AS
Total operating income 2025: NOK 169,261,838
Operating profit 2025: NOK 101,522,404
Employees: 0

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	169,261,838	159,362,476	42,621,068	41,523,685	31,023,979
Annual Total Result	80,061,632	35,139,632	-48,682,852	-74,198,630	-5,677,525
Total assets	404,220,738	341,405,814	307,187,934	380,817,143	474,177,439
Total liabilities	89,768,279	77,014,988	47,936,739	95,821,406	84,983,074
Total equity	314,452,459	264,390,827	259,251,195	284,995,735	389,194,365

P&L

Year	2025	2024	2023	2022	2021
Total operating income	169,261,838	159,362,476	42,621,068	41,523,685	31,023,979
Total operating costs	67,739,434	54,993,092	49,795,417	57,303,372	37,088,884
Operating result	101,522,404	104,369,383	-7,174,349	-15,779,687	-6,064,904
Financial income/costs	-672,549	-48,064,655	-41,508,503	-58,418,943	387,380
Profit before tax	100,849,855	56,304,729	-48,682,852	-74,198,630	-5,677,525
Total tax & extraordinary income/cost	20,788,223	21,165,097	0	0	0
Annual Total Result	80,061,632	35,139,632	-48,682,852	-74,198,630	-5,677,525

Balance overview

Year	2025	2024	2023	2022	2021
Total fixed assets	168,973,959	150,190,172	227,262,163	296,586,569	361,645,620
Total current assets	235,246,779	191,215,642	79,925,772	84,230,574	112,531,819
Total assets	404,220,738	341,405,814	307,187,934	380,817,143	474,177,439
Short term debt	89,768,279	77,014,988	47,936,739	95,821,406	84,983,074
Long term debt	0	0	0	0	0
Total liabilities	89,768,279	77,014,988	47,936,739	95,821,406	84,983,074
Contributed capital	259,251,195	259,251,195	259,251,195	284,995,735	389,194,364
Retained earnings	55,201,264	5,139,632	0	0	0
Total equity	314,452,459	264,390,827	259,251,195	284,995,735	389,194,365
Total equity and liabilities	404,220,738	341,405,814	307,187,934	380,817,141	474,177,439

Classification

21st company classification

BETA

Small company

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

AQUA PHARMA GROUP AS922 654 026